Prostate artery embolization (PAE) offers a minimally invasive treatment option for benign prostatic hyperplasia (BPH), but it’s not suitable for every individual. Certain medical conditions and anatomical factors can preclude patients from undergoing this procedure. For instance, individuals with prior pelvic radiation, active prostate or urinary tract infections, severe arterial atherosclerosis affecting pelvic vessels, or specific allergies to the embolic agents used are typically excluded. Additionally, patients with untreated bladder outlet obstruction, large bladder stones, or certain types of prostate cancers may not be appropriate candidates.
Careful patient selection is crucial for successful PAE outcomes. Identifying individuals unsuitable for the procedure minimizes the risk of complications and ensures the most effective treatment strategy is pursued. By excluding patients with contraindications, healthcare professionals can maximize the benefits of PAE for those who are most likely to experience significant symptom relief and improved quality of life. This careful selection process ultimately contributes to improved patient care and better resource allocation within the healthcare system.
